Follow us on Twitter
twitter icon@FreshPatents


Analogue patents

      

This page is updated frequently with new Analogue-related patent applications.




new patent Analogue-to-digital converter
This application relates to analogue-to-digital converters (adcs). An adc 200 has a first converter (201) for receiving an analogue input signal (ain) and outputting a time encode signal (dt), such as a pulse-width-modulated (pwm) signal, based on input signal and a first conversion gain setting (gin).
Cirrus Logic International Semiconductor Ltd.


new patent Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues
Tetradentate and octahedral metal complexes suitable for use as phosphorescent or delayed fluorescent and phosphorescent emitters in display and lighting applications.. .
Arizona Board Of Regents On Behalf Of Arizona State University


new patent Tetradentate metal complexes containing indoloacridine and its analogues
The complexes are suitable for use as phosphorescent or delayed fluorescent and phosphorescent emitters in display and lighting applications.. .

new patent Hand-gesture-based interface utilizing augmented reality
A system for providing a hand-gesture-based human-to-device interface includes an imaging device configured to record a sequence of still images and a computing device coupled in communication with the imaging device. The computing device includes a processor and a memory coupled to the processor, wherein the processor is configured to analyse the sequence of still images to identify at least one hand gesture made by a user, determine whether or not the at least one hand gesture includes at least one predefined hand gesture, identify an output signal corresponding to the at least one hand gesture, when the at least one hand gesture includes at least one predefined hand gesture, and use the output signal to control a quantity of at least one analogue parameter..
Augumenta Ltd


new patent Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
A method of screening a sample of body fluid obtained from an animal subject for analyte autoantibodies reactive with one or more antigenic molecules selected from pancreatic islet cell antigenic molecules (gad, 1a2) and insulin, or one or more variants, analogues, derivatives or fragments thereof, and a kit for use in such a method. After addition of the sample one or more complexes comprising [antigenic molecule of first source]-[analyte auto antibody]-[antigenic molecule of second source].
Rsr Limited


new patent Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
A method of screening a sample of body fluid obtained from an animal subject for analyte autoantibodies reactive with one or more antigenic molecules selected from pancreatic islet cell antigenic molecules (gad, 1a2) and insulin, or one or more variants, analogues, derivatives or fragments thereof, and a kit for use in such a method. After addition of the sample one or more complexes comprising [antigenic molecule of first source]-[analyte auto antibody]-[antigenic molecule of second source].
Rsr Limited


new patent Potent lna oligonucleotides for the inhibition of hif-1a expression
The present disclosure relates to an lna oligonucleotide consisting of a sequence selected from the group consisting of 5′-(tx)gxgxcsasasgscsastscscstxgxt-3′ and 5′-(gx)txtxascstsgscscststscstxtxa-3′, wherein capital letters designate a beta-d-oxy-lna nucleotide analogue, small letters designate a 2-deoxynucleotide, underline designates either a beta-d-oxy-lna nucleotide analogue or a 2-deoxynucleotide, subscript “s” designates a phosphorothioate link between neighbouring nucleotides/lna nucleotide analogues, and subscript “x” designates either a phosphorothioate link or a phosphorodiester link between neighbouring nucleotides/lna nucleotide analogues, and wherein the sequence is optionally extended by up to five 2-deoxynucleotide units. The lna oligonucleotides are useful for modulating the expression of hypoxia-inducible factor-1a (hif-1a), e.g.
Roche Innovation Center Copenhagen A/s


new patent Glucagon-like-peptide-2 (glp-2) analogues
Glp-2 analogues are disclosed which comprise one of more substitutions as compared to h[gly2]glp-2 and which may have the property of an altered glp-1 activity, and their medical use. The analogues are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes..
Zealand Pharma A/s


new patent Hexadepsipeptide analogues as anticancer compounds
This invention relates to a method of treatment of cancer comprising administering compound of formula (1) or derivatives or pharmaceutically acceptable salts thereof.. .
Piramal Enterprises Limited


new patent Compositions
The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use as an anticonvulsant and/or seizure suppressant, in particular in the treatment or prevention of (e.g. Juvenile) epilepsy..
Globalacorn Ltd


new patent

Composition comprising nor-adrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor

A composition, an infusion solution, a method for treatment, and a kit for intravascular administration for treatment of a brain-dead, heart-beating, respirated, potential organ donor. The composition has noradrenaline and a net inhibitor for noradrenaline.
Vivoline Medical Ab

Ad converter including a capacitive dac

An ad converter converts an analogue input voltage into a digital value including a most significant bit to a least significant bit. The ad converter includes: a common node; a capacitive dac; a comparator; a successive approximation controller; and an integrator.
Panasonic Intellectual Property Management Co., Ltd.

Glucagon analogues

The invention provides glucagon analogue peptides and their use for promoting weight loss or preventing weight gain, and the treatment of obesity or excess body weight and associated conditions. The compounds may also be used to improve glycemic control and/or for the treatment of diabetes.
Boehringer Ingelheim International Gmbh

Novel glucagon analogues

The present invention relates to novel glucagon peptides, to the use of said glucagon peptides in therapy, to methods of treatment comprising administration of said glucagon peptides to patients in need thereof, and to the use of said glucagon peptides in the manufacture of medicaments. The glucagon peptides of the present invention are of particular interest in relation to the treatment of hyperglycemia, diabetes and obesity, as well as a variety of diseases or conditions associated with hyperglycemia, diabetes and obesity..
Novo Nordisk A/s

Synthesis of duocarmycin analogues

A novel fmoc protected duocarmycin subunit and utilisation as a reagent in solid phase protein synthesis methodology. Also provided is a novel method of solid phase peptide synthesis, and in particular a method for the production of novel intermediates and novel monomeric and extended duocarmycin analogues having amino acid substituents..
University Of East Anglia

Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph

This invention provides methods of treating androgenetic alopecia (aga), acne, rosacea, prostate cancer, and benign prostatic hypertrophy (bph), comprising the step of contacting a subject with a compound or composition capable of decreasing prostaglandin d2 (pgd2) level or activity, a downstream signaling or receptor pathway thereof, or prostaglandin d2 synthase level or activity; methods of stimulating hair growth, comprising the step of contacting a subject with a compound or composition capable of increasing or decreasing the activity or level of a target gene of the present invention, or with a protein product of the target gene or an analogue or mimetic thereof; and methods of testing for aga and evaluating therapeutic methods thereof, comprising measuring pgd2 levels.. .
The Trustees Of The University Of Pennsylvania

Compositions for reducing hair loss and/or increasing hair regrowth

The invention relates to a composition comprising 2% to 5% minoxidil, 0.01% to 15% of a 5α-reductase inhibitor or an androgen receptor antagonist, and 0.01% to 15% of a prostaglandin analogue. In one embodiment, the prostaglandin analogue is latanoprost.
Triple Hair, Inc.

Itraconazole analogues and methods of use thereof

Disclosed herein are analogues of itraconazole that are both angiogenesis and hedgehog signaling pathway inhibitors. The compounds are expected to be useful in the treatment of cancer, particularly cancers that are dependent upon the hedgehog signaling pathway such as basal cell carcinoma and medulloblastoma..
University Of Connecticut

Synthesis of tetracyclines and analogues thereof

The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics.
President And Fellows Of Harvard College

Methods for chronic pain management and treatment using hcg

A gonadotropin is administered within a surprisingly effective narrow range for the purpose of treating chronic pain or other central sensitization sequelae. In one aspect, a recipient is provided with at least one of human chorionic gonadotropin (uhcg and/or rhcg), a pharmaceutically active hcg analogue, and a pharmaceutically active metabolite of the hcg or analogue at a dosage selected to provide an amount therapeutically bioequivalent to, a human subcutaneous dosage of between 120 iu/day and 170 iu/day of hcg, and more preferably between 140 iu/day and 160 iu/day of hcg.
Neuralight Hd, Llc

Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs

A process for the preparation of injectable pharmaceutical compositions for the sustained release of somatostatin analogues and compositions prepared according to the process. The process may comprise lyophilizing a mixture of lanreotide acetate and acetic acid to form a lyophilizate and hydrating the lyophilizate, wherein the lyophilization is performed only once..
Ipsen Pharma S.a.s.

Medical fluid, a treatment and use of the fluid

A medical fluid for a harvested organ, tissue or part thereof, for evaluation and/or preservation. The fluid includes cocaine or a stimulating analogue thereof; noradrenaline; and/or adrenaline.
Vivoline Medical Ab

Pyrabactin analogues to modulate plant development

The present invention relates to compounds which can be used to control plant development. Indeed, the present invention discloses a new class of pyrabactin analogues which have a physiological effect on—for example—seed germination, and/or stomatal closure, and/or have developmental effects on root and shoot development and organogenesis.
Universiteit Gent

Methods of regulating cannabinoid receptor activity-related disorders and diseases

This disclosure concerns the discovery of the use of fenoterol analogues for regulating cannabinoid (cb) receptor activity-related disorders and disease, such as dysregulated cb receptors, including treating a disorder or disease, such as a glioblastoma, hepatocellular carcinoma, liver cancer, colon cancer, and/or lung cancer, which is associated with altered cannabinoid receptor activity. In one example, the method includes administering to a subject having or at risk of developing a disorder or disease regulated by cb receptor activity an effective amount of a fenoterol analogue to reduce one or more symptoms associated with the disorder or disease regulated by cb receptor activity..
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv

Yeast mutant and yeast extract

A natural yeast extract which is rich in glutamic acid and therefore has an impact at first taste. Further, provided is a yeast extract which is also rich in 5′-guanylic acid or 5′-inosinic acid and therefore has strong umami.
Kohjin Co., Ltd.

Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same

Disclosed are a human relaxin analogue, a polynucleotide encoding the human relaxin analogue, a pharmaceutical composition comprising the human relaxin analogue, and a pharmaceutical application of the human relaxin analogue. Also disclosed is a derivative of the human relaxin analogue..
Jiangsu Hengrui Medicine Co., Ltd.

Analogue peptide cma3 derived from cm-ma peptide and use thereof

The present invention relates to a novel analogue antibiotic peptide derived from a cm-ma peptide and a use thereof. Specifically, the novel antibiotic peptides represented by seq.
Industry-academic Cooperation Foundation, Chosun University

Bicyclic heteroaryl indole analogues useful as ror gamma modulators

The present disclosure is directed to compounds of formula (i) and pharmaceutically acceptable salts thereof, wherein x, x1, m, r2, r3, r4, r5, m, n, and p are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (rorγt). These compounds prevent, inhibit, or suppress the action of rorγt and are therefore useful in the treatment of rorγt mediated diseases, disorders, syndromes or conditions such as, e.g., pain, inflammation, copd, asthma, rheumatoid arthritis, colitis, multiple sclerosis, neurodegenerative diseases and cancer..
Glenmark Pharmaceuticals S.a.

Morphan and morphinan analogues, and methods of use

The present application relates to analogues of morphan and morphinan, compositions thereof, and methods for treating a disease or condition comprising administering an effective amount of the compounds or compositions to a subject in need thereof.. .
Alkermes Pharma Ireland Limited

Process for the synchronization of ovulation for timed breeding without heat detection

A method for synchronizing ovulation in sows and gilts by a single injection of hormones is disclosed. A hormone, gonadotropin releasing hormone (gnrh), luteinizing hormone (lh), follicle stimulating hormone (fsh), human chorionic gonadotropin (hcg), analogues, derivatives, agonists or combinations thereof is administered to an open sow post weaning at a specific time to stimulate ovulation of mature responsive follicles.
Thorn Bioscience Llc

Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants

A pharmaceutical composition comprising a vitamin d derivative or analogue as the active ingredient dissolved in a three-component surfactant-solvent mixture is useful in the treatment of dermal disorders or conditions.. .
Leo Pharma A/s

Dosage forms and related therapies

This invention is directed in part to novel doses, dosage formulations, and routes of administration of such doses and dose formulations, said dose and dose formulations containing one or more copper chelators, for example, one or more trientine active agents, including trientine analogues, trientine salts, trientine prodrugs, and trientine derivatives, useful in the treatment of diseases, disorders and conditions, including in indications where copper may play a role.. .
Philera New Zealand Limited

Protection device for electrical network

A device for protecting a medium or high voltage electrical network is provided, including a base part connected to means for measuring values representative of the electrical network and to a trip circuit of the electrical network, an active part that includes means for analogue-digital conversion of the values representative of the electrical network and which is mechanically and electrically connected to the base part in a first position referred to as the normal position, and a removable test part that is mechanically and electrically connected to the active part in a second position referred to as the test position. The test part includes means for mechanically and electrically connecting to the base part such that, in the test position, external terminals of the test part are connected to the trip circuit through the base part..
Schneider Electric Industries Sas

Gamma-aminobutyric acid (gaba) analogues for the treatment of pain and other disorders

A compound of formula (1) wherein r1 represents hydrogen, halo, a c1-c4 alkyl group, a c1-c4 alkylhalide group, a c1-c4 alkoxy-c2-c4 alkyl group, a c2-c4 alkenyl group, a c2-c4 alkynyl group or a c3-c7 cyclo alkyl group; r2 represents formula (1)′ or formula (1)″ a tautomer thereof; and r3 represents hydrogen, a c1-c4 alkyl group, a c1-c4 alkoxy-c2-c4 alkyl group or a c7 cyclo alkyl group; or a pharmaceutically acceptable salt or solvate thereof. Processes to prepare said compounds and novel intermediates are also claimed.
Novassay S.a.

Using multiple correlators to determine signal sent and frequency offset

A digital radio receiver 54 is adapted to receive radio signals which are modulated using continuous phase modulation. The receiver comprises means for receiving an analogue radio signal having a carrier frequency, a plurality of correlators 6, 8 each corresponding to a different bit sequence which share a common estimator 4 for estimating a frequency offset between said carrier frequency and a nominal carrier frequency, and means 12 for determining which of said correlators 6, 8 produces a desired output signal..
Nordic Semiconductor Asa

Wireless receiver and method

A receiver and method for a wireless signal transmission system use digital amplitude modulation of a base band signal having a symbol clock frequency. The receiver includes a reference generator which generates a local reference frequency, a mixer to extract the base band signal, a high pass filter to suppress a dc component, an amplifier, an analogue-to-digital converter and a digital signal processor to receive digital signals and extract symbols.
Nxp B.v.

Enzymatic production of cytosinic nucleoside analogues

The invention relates to the enzymatic production of cytosinic nucleoside analogues. In particular it relates to a new synthesis process of cytosine nucleoside analogues by using nucleoside phosphorylase enzymes, particularly pyrimidin nucleoside phosphorylases (pynps) or mixtures of purine nucleoside phosphorylases (pnps) and pynps..
Plasmia Biotech, S.l.

Industrial process for the synthesis of ulipristal acetate and its 4'-acetyl analogue

The present invention relates to a new process for the synthesis of compounds of formula (i) (wherein the meaning of r is dimethylamino or acetyl group) using the compound of formula (ii) (wherein the meaning of r is dimethylamino or 2-methyl-1,3-dioxolan-2-yl group) as starting material, as well as to the intermediate of the process.. .
Richter Gedeon Nyrt.

Docosahexaenoyl ethanolamides

The invention describes novel mono or dihydroxy docosahexaenoic acid (dha) analogues, their preparation, isolation, identification, purification and uses thereof.. .
The Brigham And Women's Hospital, Inc.

Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions

Polymer and drug containing compositions and method of preparing such compositions are disclosed. The dispersed phase formulation has a polymer, a pharmaceutically or biologically active agent and a small fraction of low pka acid additive.
Oakwood Laboratories, Llc

Treatment of gum diseases and gum disorders with tsg-6 protein

A method of treating or preventing a gum disease or gum disorder or gum injury in a mammal by administering to the mammal at least one inflammation modulatory or anti-inflammatory protein or polypeptide, such as tsg-6 protein, or a biologically active fragment, derivative, or analogue thereof. Gum diseases or gum disorders or gum injuries that may be treated include periodontal gum disease, and gum wounds resulting from gum surgeries..

Pre-compensation of the phase shifting error

In this disclosure, methods for pre-compensation of the phase shifting error, and apparatuses for the same are disclosed. In one example, a device performs precoding of a digital signal, while acquiring information on an error caused by a phase shifting of the precoding.
Lg Electronics Inc.

Digitally assisted current sense circuit and digitizing a sensed signal

A method for digitizing a sensed signal in a digitally assisted current sense circuit and a digitally assisted current sense circuit that uses the disclosed method realize a simple way to sense and convert an analogue current signal into a digital signal. The method includes the steps of generating a voltage corresponding to a sensed inductor current il; and amplifying and buffering the voltage for creating an input signal to be converted by an analogue-to-digital converter (adc).
Zentrum Mikroelektronik Dresden Ag

Glucagon analogues

The invention provides materials and methods for promoting weight loss or preventing weight gain without affecting glycemic control. In particular, the invention provides novel glucagon analogue peptides effective in such methods.
Zealand Pharma A/s

Fused tricyclic imidazole derivatives as modulators of tnf activity

A series of substituted fused tricyclic imidazole derivatives, in particular dihydro-1h-pyrano[4′,3′:4,5]imidazo[1,2-a]pyridine, 1,2,3,4-tetrahydroimidazo[1,2-a:5,4-c′]dipyridine, dihydro-1h-pyrano[3′,4′:4,5]imidazo[1,2-a]pyridine and tetrahydro-6h-cyclohepta[4,5]imidazo[1,2-a]pyridine, and analogues thereof, being potent modulators of human tnf activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.. .
Ucb Biopharma Sprl

Novel opioid compounds and their uses

The present invention relates to opioid compounds, especially to c14 esters and ethers of naltrexone and analogues thereof. The present invention also relates to compositions, methods and medical uses that employ such compounds.
Sri International

Fused tricyclic benzimidazoles derivatives as modulators of tnf activity

A series of tricyclic benzimidazole derivatives, in particular dihydro-1h-imidazo [1,2-a]benzimidazole, dihydro-1h-pyrrolo [1,2-a]benzimidazole, dihydro-1h-pyrazino[1,2-a]benzimidazole, dihydro-1h-[1,4]oxazino[4,3-a]benzimidazole and dihydrothiazolo[3,4-a]benzimidazolem, and analogues thereof, being potent modulators of human tnfa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.. .
Ucb Biopharma Sprl

Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

Embodiments of the present invention provide a method for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, and chronic sinusitis, including cystic fibrosis, interstitial fibrosis, chronic bronchitis, emphysema, bronchopulmonary dysplasia and neoplasia. The method involves administration, preferably oral, nasal or pulmonary administration, of anti-inflammatory and anti-proliferative drugs (rapamycin or paclitaxel and their analogues) and an additive..
Lutonix, Inc.

Methods of detecting and measuring glutamine and analogues thereof, and methods related thereto

Method for the detection of glutamine and its analogues are provided by the present disclosure. Also provided are methods for measuring the levels of glutamine and its analogues, including diagnostic methods.
Victoria Link Limited



Analogue topics:
  • Carbon Dioxide
  • Amino Acid
  • Radio Signal
  • Inorganic Compounds
  • Hydrogen Production From Water
  • Electrolysis
  • Semiconductor
  • High Energy
  • Semiconductor Material
  • Transmitter
  • Synchronization
  • Concurrent
  • Surfactant
  • Hyperglycemia
  • Pharmaceutically Acceptable Salt


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Analogue for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Analogue with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.8878

    file did exist - 2267

    2 - 1 - 51